Literature DB >> 28083883

A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy.

Haixia Qiu1,2, Michele M Kim1,3, Rozhin Penjweini1, Jarod C Finlay1, Theresa M Busch1, Tianhao Wang4, Wensheng Guo4, Keith A Cengel1, Charles B Simone1, Eli Glatstein1, Timothy C Zhu1.   

Abstract

This preclinical study examines light fluence, photodynamic therapy (PDT) dose and "apparent reacted singlet oxygen," [1 O2 ]rx , to predict local control rate (LCR) for Photofrin-mediated PDT of radiation-induced fibrosarcoma (RIF) tumors. Mice bearing RIF tumors were treated with in-air fluences (50-250 J cm-2 ) and in-air fluence rates (50-150 mW cm-2 ) at Photofrin dosages of 5 and 15 mg kg-1 and a drug-light interval of 24 h using a 630-nm, 1-cm-diameter collimated laser. A macroscopic model was used to calculate [1 O2 ]rx and PDT dose based on in vivo explicit dosimetry of the drug concentration, light fluence and tissue optical properties. PDT dose and [1 O2 ]rx were defined as a temporal integral of drug concentration and fluence rate, and singlet oxygen concentration consumed divided by the singlet oxygen lifetime, respectively. LCR was stratified for different dose metrics for 74 mice (66 + 8 control). Complete tumor control at 14 days was observed for [1 O2 ]rx ≥ 1.1 mm or PDT dose ≥1200 μm J cm-2 but cannot be predicted with fluence alone. LCR increases with increasing [1 O2 ]rx and PDT dose but is not well correlated with fluence. Comparing dosimetric quantities, [1 O2 ]rx outperformed both PDT dose and fluence in predicting tumor response and correlating with LCR.
© 2017 The American Society of Photobiology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28083883      PMCID: PMC5500427          DOI: 10.1111/php.12719

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  34 in total

1.  Mathematical modelling of oxygen transport to tissue.

Authors:  Jonathan P Whiteley; David J Gavaghan; Clive E W Hahn
Journal:  J Math Biol       Date:  2002-06       Impact factor: 2.259

2.  Modeling of a type II photofrin-mediated photodynamic therapy process in a heterogeneous tissue phantom.

Authors:  Xin-Hua Hu; Yuanming Feng; Jun Q Lu; Ron R Allison; Rosa E Cuenca; Gordon H Downie; Claudio H Sibata
Journal:  Photochem Photobiol       Date:  2005 Nov-Dec       Impact factor: 3.421

3.  Pretreatment photosensitizer dosimetry reduces variation in tumor response.

Authors:  Xiaodong Zhou; Brian W Pogue; Bin Chen; Eugene Demidenko; Rohan Joshi; Jack Hoopes; Tayyaba Hasan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-03-15       Impact factor: 7.038

4.  Effect of photosensitizer dose on fluence rate responses to photodynamic therapy.

Authors:  Hsing-Wen Wang; Elizabeth Rickter; Min Yuan; E Paul Wileyto; Eli Glatstein; Arjun Yodh; Theresa M Busch
Journal:  Photochem Photobiol       Date:  2007 Sep-Oct       Impact factor: 3.421

5.  A comprehensive mathematical model of microscopic dose deposition in photodynamic therapy.

Authors:  Ken Kang-Hsin Wang; Soumya Mitra; Thomas H Foster
Journal:  Med Phys       Date:  2007-01       Impact factor: 4.071

6.  Broadband reflectance measurements of light penetration, blood oxygenation, hemoglobin concentration, and drug concentration in human intraperitoneal tissues before and after photodynamic therapy.

Authors:  Hsing-Wen Wang; Timothy C Zhu; Mary E Putt; Michael Solonenko; James Metz; Andreea Dimofte; Jeremy Miles; Douglas L Fraker; Eli Glatstein; Stephen M Hahn; Arjun G Yodh
Journal:  J Biomed Opt       Date:  2005 Jan-Feb       Impact factor: 3.170

7.  Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling.

Authors:  Ken Kang-Hsin Wang; Jarod C Finlay; Theresa M Busch; Stephen M Hahn; Timothy C Zhu
Journal:  J Biophotonics       Date:  2010-06       Impact factor: 3.207

8.  PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model.

Authors:  Imran Rizvi; Sriram Anbil; Nermina Alagic; Jonathan Celli; Jonathan P Celli; Lei Zak Zheng; Akilan Palanisami; Michael D Glidden; Brian W Pogue; Tayyaba Hasan
Journal:  Photochem Photobiol       Date:  2013-04-04       Impact factor: 3.421

Review 9.  Photodynamic therapy for cancer.

Authors:  Dennis E J G J Dolmans; Dai Fukumura; Rakesh K Jain
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

10.  Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate.

Authors:  T M Sitnik; J A Hampton; B W Henderson
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

View more
  7 in total

1.  Reactive Oxygen Species Explicit Dosimetry for Photofrin-mediated Pleural Photodynamic Therapy.

Authors:  Yi Hong Ong; Andreaa Dimofte; Michele M Kim; Jarod C Finlay; Tianqi Sheng; Sunil Singhal; Keith A Cengel; Arjun G Yodh; Theresa M Busch; Timothy C Zhu
Journal:  Photochem Photobiol       Date:  2019-12-06       Impact factor: 3.421

2.  PDT dose dosimetry for Photofrin-mediated pleural photodynamic therapy (pPDT).

Authors:  Yi Hong Ong; Michele M Kim; Jarod C Finlay; Andreea Dimofte; Sunil Singhal; Eli Glatstein; Keith A Cengel; Timothy C Zhu
Journal:  Phys Med Biol       Date:  2017-12-29       Impact factor: 3.609

3.  1O2 determined from the measured PDT dose and 3O2 predicts long-term response to Photofrin-mediated PDT.

Authors:  Rozhin Penjweini; Michele M Kim; Yi Hong Ong; Timothy C Zhu
Journal:  Phys Med Biol       Date:  2020-01-24       Impact factor: 3.609

4.  Effects of patient-specific treatment planning on eligibility for photodynamic therapy of deep tissue abscess cavities: retrospective Monte Carlo simulation study.

Authors:  Zihao Li; Lam Nguyen; David A Bass; Timothy M Baran
Journal:  J Biomed Opt       Date:  2022-02       Impact factor: 3.170

5.  An Analysis of the Effects of In Vitro Photodynamic Therapy on Prostate Cancer Tissue by Histopathological Examination and Magnetic Resonance Imaging.

Authors:  David Aebisher; Michał Osuchowski; Dorota Bartusik-Aebisher; Magdalena Krupka-Olek; Klaudia Dynarowicz; Aleksandra Kawczyk-Krupka
Journal:  Int J Mol Sci       Date:  2022-09-26       Impact factor: 6.208

Review 6.  Porphyrin photosensitizers in photodynamic therapy and its applications.

Authors:  Jiayuan Kou; Dou Dou; Liming Yang
Journal:  Oncotarget       Date:  2017-08-11

Review 7.  Recent Advances in Porphyrin-Based Inorganic Nanoparticles for Cancer Treatment.

Authors:  Hanieh Montaseri; Cherie Ann Kruger; Heidi Abrahamse
Journal:  Int J Mol Sci       Date:  2020-05-09       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.